Structure Therapeutics (NASDAQ: GPCR) received a significant boost in its price target from JPMorgan Chase & Co., which raised it from $65.00 to $105.00...
Amphenol Corporation (NYSE: APH) has garnered a consensus rating of “Moderate Buy” from analysts, with thirteen brokerages covering the company. According to MarketBeat Ratings,...